The global spatial genomics and transcriptomics market is projected to reach USD 800 million by 2027 from USD 355 million in 2022, at a CAGR of 17.6% during the forecast period. Market growth is largely driven by the shift from strictly research applications to drug discovery & development for areas such as neurodegenerative diseases and cancer. Spatial genomics and transcriptomics are also anticipated to address current unmet clinical needs in oncology, including the demand for predictive biomarkers of response. These biomarkers assist in developing immunotherapies by offering a greater understanding of the tumor. On the other hand, lack of clarity around outcomes of transcriptomic research, coupled with the high equipment cost, has led to the lower adoption of transcriptomic technologies, thereby limiting the growth of the spatial genomics & transcriptomics market.
By application, translational research accounted for the largest share of the spatial genomics & transcriptomics market
Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations.
Asia Pacific: The fastest-growing region in the spatial genomics & transcriptomics market
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the growing biopharmaceutical industry, increasing R&D spending in Asian countries is one of the major factors driving growth. In addition, Asian economies have modified regulations, policies, and guidelines to promote innovation and commercialization, attracting many domestic industrialists and global market leaders to establish their businesses in this region.
North America: the largest share of the spatial genomics & transcriptomics market
North America accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding for the development of new regenerative medicine, and technological advancements and launch of cell therapies to treat different cancers are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side - 60% and Demand Side - 40%
- By Designation: Executives - 40%, Research Scientists - 30%, and Managers - 30%
- By Region: North America - 51%, Europe - 25%, Asia-Pacific - 18%, Latin America - 3%, Middle East and Africa - 3%
Major Players
- NanoString Technologies, Inc. (US)
- 10X Genomics (US)
- Illumina (US)
- Bio-Rad Laboratories (US)
- Bio-Techne Corporation (US)
- Standard BioTools Inc. (US)
- Genomic Vision SA (France)
- Akoya Biosciences, Inc. (US)
- Danaher Corporation (US)
- Natera, Inc. (US)
- PerkinElmer, Inc. (US)
- Seven Bridges Genomics (US)
- S2 Genomics, Inc. (US)
- Cantata Bio (US)
- Vizgen Corporation (US)
- BioSpyder Technologies Inc. (US)
- Optical Biosystems Inc. (US)
- Miltenyi Biotec (Germany)
- Ultivue Inc. (US)
- Lunaphore Technologies SA (Switzerland)
- Rebus Biosystems LLC (US)
- Resolve Biosciences (Germany)
- Singular Genomics, Inc. (US)
- Veracyte (US)
Research Coverage:
This report provides a detailed picture of the spatial genomics & trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
Table of Contents
1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Study Scope
1.4 Years Considered
1.5 Currency Considered
1.6 Limitations
1.7 Stakeholders
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Study Scope
1.4 Years Considered
1.5 Currency Considered
1.6 Limitations
1.7 Stakeholders
2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 2 Breakdown of Primaries: Spatial Genomics and Transcriptomics Market
2.2 Market Estimation Methodology
Figure 3 Market Size Estimation (Company Revenue Analysis-Based Estimation)
Figure 4 Spatial Genomics & Transcriptomics Market Size, 2021 (USD Million)
Figure 5 Spatial Genomics & Transcriptomics Market: Final CAGR Projections (2022-2027)
Figure 6 Spatial Genomics & Transcriptomics Market: CAGR Projections from Analysis of Demand-Side Drivers, Opportunities, and Challenges
2.3 Market Data Estimation & Triangulation
2.3.1 Data Triangulation
Figure 7 Data Triangulation Methodology
2.4 Industry Insights
2.5 Research Assumptions
Figure 1 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 2 Breakdown of Primaries: Spatial Genomics and Transcriptomics Market
2.2 Market Estimation Methodology
Figure 3 Market Size Estimation (Company Revenue Analysis-Based Estimation)
Figure 4 Spatial Genomics & Transcriptomics Market Size, 2021 (USD Million)
Figure 5 Spatial Genomics & Transcriptomics Market: Final CAGR Projections (2022-2027)
Figure 6 Spatial Genomics & Transcriptomics Market: CAGR Projections from Analysis of Demand-Side Drivers, Opportunities, and Challenges
2.3 Market Data Estimation & Triangulation
2.3.1 Data Triangulation
Figure 7 Data Triangulation Methodology
2.4 Industry Insights
2.5 Research Assumptions
3 Executive Summary
Figure 8 Spatial Genomics & Transcriptomics Market, by Product, 2021 Vs. 2027 (USD Million)
Figure 9 Spatial Genomics & Transcriptomics Market, by Technique, 2021 Vs. 2027 (USD Million)
Figure 10 Spatial Genomics & Transcriptomics Market Share, by Application, 2021 Vs. 2027
Figure 11 Spatial Genomics & Transcriptomics Market, by End-user, 2021 Vs. 2027 (USD Million)
Figure 12 Geographical Snapshot
Figure 9 Spatial Genomics & Transcriptomics Market, by Technique, 2021 Vs. 2027 (USD Million)
Figure 10 Spatial Genomics & Transcriptomics Market Share, by Application, 2021 Vs. 2027
Figure 11 Spatial Genomics & Transcriptomics Market, by End-user, 2021 Vs. 2027 (USD Million)
Figure 12 Geographical Snapshot
4 Premium Insights
4.1 Spatial Genomics & Transcriptomics Market Overview
Figure 13 Increasing Adoption of Spatial Genomics & Transcriptomics Analysis in Translational Research to Drive Market Growth
4.2 North America: Spatial Genomics & Transcriptomics Market Share, by Product & Country (2021)
Figure 14 Consumables Accounted for Largest Share in 2021
4.3 Spatial Genomics & Transcriptomics Market Share, by End-user (2021)
Figure 15 Academic & Research Institutes Accounted for Largest Market Share in 2021
Figure 13 Increasing Adoption of Spatial Genomics & Transcriptomics Analysis in Translational Research to Drive Market Growth
4.2 North America: Spatial Genomics & Transcriptomics Market Share, by Product & Country (2021)
Figure 14 Consumables Accounted for Largest Share in 2021
4.3 Spatial Genomics & Transcriptomics Market Share, by End-user (2021)
Figure 15 Academic & Research Institutes Accounted for Largest Market Share in 2021
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 16 Spatial Genomics & Transcriptomics Market: Drivers, Restraints, Opportunities, and Challenges
Table 1 Spatial Genomics & Transcriptomics Market: Impact Analysis
5.2.1 Drivers
5.2.1.1 Increasing Adoption of Spatial Genomics & Transcriptomics in Drug Discovery & Development
5.2.1.2 Introduction of Novel Products
5.2.1.3 Increasing R&D Investments and Public-Private Funding
5.2.2 Restraints
5.2.2.1 High Capital Investments
5.2.3 Opportunities
5.2.3.1 Increasing Use of Spatial Omics for Biomarker Identification
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Professionals
5.3 Technology Analysis
5.3.1 Multiplexing
5.3.2 Imaging-Based Technological Advancements
5.3.3 Data Analysis
5.4 Trends/Disruptions Impacting Customer's Business
Figure 17 Trends/Disruptions Impacting Customer's Business
5.5 Supply Chain Analysis
Figure 18 Spatial Genomics & Transcriptomics Market: Supply Chain Analysis
5.6 Value Chain Analysis
Figure 19 Spatial Genomics & Transcriptomics Market: Value Chain Analysis
5.7 Ecosystem Analysis
Figure 20 Spatial Genomics & Transcriptomics Market: Ecosystem Analysis
5.8 Porter's Five Forces Analysis
Table 2 Spatial Genomics & Transcriptomics Market: Porter's Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Threat of Substitutes
5.8.3 Bargaining Power of Buyers
5.8.4 Bargaining Power of Suppliers
5.8.5 Degree of Competition
5.9 Regulatory Analysis
5.9.1 Fda Approvals
5.9.2 Regulatory Bodies, Government Agencies, and Other Organizations
Table 3 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 4 Europe: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 5 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 6 RoW: List of Regulatory Bodies, Government Agencies, and Other Organizations
5.10 Pricing Analysis
Table 7 Pricing Analysis of Spatial Genomics and Transcriptomics Products
5.10.1 Spatial Genomics & Transcriptomics Market: Average Selling Price Trend
5.11 Pipeline Analysis
5.12 Key Conferences & Events in 2022-2023
5.12.1 Spatial Genomics and Transcriptomics Conferences (2022-2023)
Table 8 Spatial Genomics and Transcriptomics Conferences (2022-2023)
5.13 Key Stakeholders and Buying Criteria
5.13.1 Key Stakeholders in Buying Process
Figure 21 Influence of Stakeholders on Buying Process
5.13.2 Buying Criteria for Spatial Genomics and Transcriptomics
Figure 22 Key Buying Criteria for End-users
5.2 Market Dynamics
Figure 16 Spatial Genomics & Transcriptomics Market: Drivers, Restraints, Opportunities, and Challenges
Table 1 Spatial Genomics & Transcriptomics Market: Impact Analysis
5.2.1 Drivers
5.2.1.1 Increasing Adoption of Spatial Genomics & Transcriptomics in Drug Discovery & Development
5.2.1.2 Introduction of Novel Products
5.2.1.3 Increasing R&D Investments and Public-Private Funding
5.2.2 Restraints
5.2.2.1 High Capital Investments
5.2.3 Opportunities
5.2.3.1 Increasing Use of Spatial Omics for Biomarker Identification
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Professionals
5.3 Technology Analysis
5.3.1 Multiplexing
5.3.2 Imaging-Based Technological Advancements
5.3.3 Data Analysis
5.4 Trends/Disruptions Impacting Customer's Business
Figure 17 Trends/Disruptions Impacting Customer's Business
5.5 Supply Chain Analysis
Figure 18 Spatial Genomics & Transcriptomics Market: Supply Chain Analysis
5.6 Value Chain Analysis
Figure 19 Spatial Genomics & Transcriptomics Market: Value Chain Analysis
5.7 Ecosystem Analysis
Figure 20 Spatial Genomics & Transcriptomics Market: Ecosystem Analysis
5.8 Porter's Five Forces Analysis
Table 2 Spatial Genomics & Transcriptomics Market: Porter's Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Threat of Substitutes
5.8.3 Bargaining Power of Buyers
5.8.4 Bargaining Power of Suppliers
5.8.5 Degree of Competition
5.9 Regulatory Analysis
5.9.1 Fda Approvals
5.9.2 Regulatory Bodies, Government Agencies, and Other Organizations
Table 3 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 4 Europe: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 5 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 6 RoW: List of Regulatory Bodies, Government Agencies, and Other Organizations
5.10 Pricing Analysis
Table 7 Pricing Analysis of Spatial Genomics and Transcriptomics Products
5.10.1 Spatial Genomics & Transcriptomics Market: Average Selling Price Trend
5.11 Pipeline Analysis
5.12 Key Conferences & Events in 2022-2023
5.12.1 Spatial Genomics and Transcriptomics Conferences (2022-2023)
Table 8 Spatial Genomics and Transcriptomics Conferences (2022-2023)
5.13 Key Stakeholders and Buying Criteria
5.13.1 Key Stakeholders in Buying Process
Figure 21 Influence of Stakeholders on Buying Process
5.13.2 Buying Criteria for Spatial Genomics and Transcriptomics
Figure 22 Key Buying Criteria for End-users
6 Spatial Genomics & Transcriptomics Market, by Technique
6.1 Introduction
Table 9 Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
6.2 Spatial Transcriptomics
Table 10 Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 11 Spatial Transcriptomics Market, by Region, 2020-2027 (USD Million)
Table 12 North America: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 13 Europe: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 14 Asia-Pacific: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 15 Latin America: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 16 Middle East & Africa: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
6.2.1 Immunohistochemistry
6.2.1.1 Emergence of Mihc/If to Propel Growth
Table 17 Immunohistochemistry Market, by Region, 2020-2027 (USD Million)
Table 18 North America: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
Table 19 Europe: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
Table 20 Asia-Pacific: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
Table 21 Latin America: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
Table 22 Middle East & Africa: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
6.2.2 in Situ Hybridization
6.2.2.1 High Adoption of Merfish to Drive Growth
Table 23 in Situ Hybridization Market, by Region, 2020-2027 (USD Million)
Table 24 North America: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 25 Europe: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 26 Asia-Pacific: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 27 Latin America: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 28 Middle East & Africa: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
6.2.3 Sequencing
Table 29 Sequencing Market, by Region, 2020-2027 (USD Million)
Table 30 North America: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
Table 31 Europe: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
Table 32 Asia-Pacific: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
Table 33 Latin America: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
Table 34 Middle East & Africa: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
6.2.3.1 Microdissection-Based Sequencing
6.2.3.1.1 Increasing Use of Microdissection-Based Sequencing to Contribute to Market Growth
6.2.3.2 in Situ Sequencing
6.2.3.2.1 Increased Adoption of in Situ Sequencing Likely to Boost Market Growth
6.2.4 Other Sequencing Technologies
6.2.5 Microscopy-Based Rna Imaging
6.2.5.1 Rising Use of Microscopy-Based Rna Imaging in Cancer Research and Diagnosis to Drive Growth
Table 35 Microscopy-Based Rna Imaging Market, by Region, 2020-2027 (USD Million)
Table 36 North America: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
Table 37 Europe: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
Table 38 Asia-Pacific: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
Table 39 Latin America: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
Table 40 Middle East & Africa: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
6.2.6 Other Spatial Transcriptomics Techniques
6.3 Spatial Genomics Analysis
Table 41 Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 42 Spatial Genomics Analysis Market, by Region, 2020-2027 (USD Million)
Table 43 North America: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
Table 44 Europe: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
Table 45 Asia-Pacific: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
Table 46 Latin America: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
Table 47 Middle East & Africa: Other Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
6.3.1 Fluorescence in Situ Hybridization
6.3.1.1 Emerging Potential of Spatial Genomics Analysis in Cancer Diagnostics to Support Market Growth
Table 48 Fluorescence in Situ Hybridization Market, by Region, 2020-2027 (USD Million)
Table 49 North America: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 50 Europe: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 51 Asia-Pacific: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 52 Latin America: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 53 Middle East & Africa: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
6.3.2 Sequencing
6.3.2.1 Rising Adoption of Massively Parallel Sequencing to Drive Growth
Table 54 Sequencing Techniques Market for Spatial Genomics Analysis, by Region, 2020-2027 (USD Million)
Table 55 North America: Sequencing Market, by Country, 2020-2027 (USD Million)
Table 56 Europe: Sequencing Market, by Country, 2020-2027 (USD Million)
Table 57 Asia-Pacific: Sequencing Market, by Country, 2020-2027 (USD Million)
Table 58 Latin America: Sequencing Market, by Country, 2020-2027 (USD Million)
Table 59 Middle East & Africa: Sequencing Market, by Country, 2020-2027 (USD Million)
6.3.3 Other Spatial Genomics Analysis Techniques
Table 60 Other Spatial Genomics Analysis Techniques Market, by Region, 2020-2027 (USD Million)
Table 61 North America: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 62 Europe: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 63 Asia-Pacific: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 64 Latin America: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 65 Middle East & Africa: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 9 Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
6.2 Spatial Transcriptomics
Table 10 Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 11 Spatial Transcriptomics Market, by Region, 2020-2027 (USD Million)
Table 12 North America: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 13 Europe: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 14 Asia-Pacific: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 15 Latin America: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 16 Middle East & Africa: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
6.2.1 Immunohistochemistry
6.2.1.1 Emergence of Mihc/If to Propel Growth
Table 17 Immunohistochemistry Market, by Region, 2020-2027 (USD Million)
Table 18 North America: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
Table 19 Europe: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
Table 20 Asia-Pacific: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
Table 21 Latin America: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
Table 22 Middle East & Africa: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
6.2.2 in Situ Hybridization
6.2.2.1 High Adoption of Merfish to Drive Growth
Table 23 in Situ Hybridization Market, by Region, 2020-2027 (USD Million)
Table 24 North America: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 25 Europe: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 26 Asia-Pacific: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 27 Latin America: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 28 Middle East & Africa: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
6.2.3 Sequencing
Table 29 Sequencing Market, by Region, 2020-2027 (USD Million)
Table 30 North America: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
Table 31 Europe: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
Table 32 Asia-Pacific: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
Table 33 Latin America: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
Table 34 Middle East & Africa: Sequencing Market for Transcriptomics, by Country, 2020-2027 (USD Million)
6.2.3.1 Microdissection-Based Sequencing
6.2.3.1.1 Increasing Use of Microdissection-Based Sequencing to Contribute to Market Growth
6.2.3.2 in Situ Sequencing
6.2.3.2.1 Increased Adoption of in Situ Sequencing Likely to Boost Market Growth
6.2.4 Other Sequencing Technologies
6.2.5 Microscopy-Based Rna Imaging
6.2.5.1 Rising Use of Microscopy-Based Rna Imaging in Cancer Research and Diagnosis to Drive Growth
Table 35 Microscopy-Based Rna Imaging Market, by Region, 2020-2027 (USD Million)
Table 36 North America: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
Table 37 Europe: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
Table 38 Asia-Pacific: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
Table 39 Latin America: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
Table 40 Middle East & Africa: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
6.2.6 Other Spatial Transcriptomics Techniques
6.3 Spatial Genomics Analysis
Table 41 Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 42 Spatial Genomics Analysis Market, by Region, 2020-2027 (USD Million)
Table 43 North America: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
Table 44 Europe: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
Table 45 Asia-Pacific: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
Table 46 Latin America: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
Table 47 Middle East & Africa: Other Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
6.3.1 Fluorescence in Situ Hybridization
6.3.1.1 Emerging Potential of Spatial Genomics Analysis in Cancer Diagnostics to Support Market Growth
Table 48 Fluorescence in Situ Hybridization Market, by Region, 2020-2027 (USD Million)
Table 49 North America: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 50 Europe: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 51 Asia-Pacific: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 52 Latin America: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
Table 53 Middle East & Africa: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
6.3.2 Sequencing
6.3.2.1 Rising Adoption of Massively Parallel Sequencing to Drive Growth
Table 54 Sequencing Techniques Market for Spatial Genomics Analysis, by Region, 2020-2027 (USD Million)
Table 55 North America: Sequencing Market, by Country, 2020-2027 (USD Million)
Table 56 Europe: Sequencing Market, by Country, 2020-2027 (USD Million)
Table 57 Asia-Pacific: Sequencing Market, by Country, 2020-2027 (USD Million)
Table 58 Latin America: Sequencing Market, by Country, 2020-2027 (USD Million)
Table 59 Middle East & Africa: Sequencing Market, by Country, 2020-2027 (USD Million)
6.3.3 Other Spatial Genomics Analysis Techniques
Table 60 Other Spatial Genomics Analysis Techniques Market, by Region, 2020-2027 (USD Million)
Table 61 North America: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 62 Europe: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 63 Asia-Pacific: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 64 Latin America: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
Table 65 Middle East & Africa: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)
7 Spatial Genomics & Transcriptomics Market, by Product
7.1 Introduction
Table 66 Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
7.2 Consumables
7.2.1 Growing Use of Consumables for Various Spatial Genomics and Transcriptomics Applications to Drive Market Growth
Table 67 Spatial Genomics and Transcriptomics Consumables Market, by Region, 2020-2027 (USD Million)
Table 68 North America: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
Table 69 Europe: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
Table 70 Asia-Pacific: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
Table 71 Latin America: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
Table 72 Middle East & Africa: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
7.3 Instruments
7.3.1 Introduction of Novel Instruments to Drive Market
Table 73 Spatial Genomics and Transcriptomics Instruments Market, by Region, 2020-2027 (USD Million)
Table 74 North America: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
Table 75 Europe: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
Table 76 Asia-Pacific: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
Table 77 Latin America: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
Table 78 Middle East & Africa: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
7.4 Software
7.4.1 Rising Use of Spatial Omics for Disease Diagnosis to Propel Demand for Software
Table 79 Spatial Genomics and Transcriptomics Software Market, by Region, 2020-2027 (USD Million)
Table 80 North America: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 81 Europe: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 82 Asia-Pacific: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 83 Latin America: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 84 Middle East & Africa: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 66 Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
7.2 Consumables
7.2.1 Growing Use of Consumables for Various Spatial Genomics and Transcriptomics Applications to Drive Market Growth
Table 67 Spatial Genomics and Transcriptomics Consumables Market, by Region, 2020-2027 (USD Million)
Table 68 North America: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
Table 69 Europe: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
Table 70 Asia-Pacific: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
Table 71 Latin America: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
Table 72 Middle East & Africa: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
7.3 Instruments
7.3.1 Introduction of Novel Instruments to Drive Market
Table 73 Spatial Genomics and Transcriptomics Instruments Market, by Region, 2020-2027 (USD Million)
Table 74 North America: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
Table 75 Europe: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
Table 76 Asia-Pacific: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
Table 77 Latin America: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
Table 78 Middle East & Africa: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
7.4 Software
7.4.1 Rising Use of Spatial Omics for Disease Diagnosis to Propel Demand for Software
Table 79 Spatial Genomics and Transcriptomics Software Market, by Region, 2020-2027 (USD Million)
Table 80 North America: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 81 Europe: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 82 Asia-Pacific: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 83 Latin America: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
Table 84 Middle East & Africa: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)
8 Spatial Genomics & Transcriptomics Market, by Application
8.1 Introduction
Table 85 Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
8.2 Translational Research
8.2.1 Demand for Spatial Transcriptomics in Understanding Tumor Microenvironment to Drive Segment Growth
Table 86 Spatial Genomics & Transcriptomics Market for Translational Research, by Region, 2020-2027 (USD Million)
Table 87 North America: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
Table 88 Europe: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
Table 89 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
Table 90 Latin America: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
Table 91 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
8.3 Drug Discovery & Development
8.3.1 Rising Use of Rna-Seq in Drug Discovery to Drive Market
Table 92 Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Region, 2020-2027 (USD Million)
Table 93 North America: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 94 Europe: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 95 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 96 Latin America: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 97 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 85 Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
8.2 Translational Research
8.2.1 Demand for Spatial Transcriptomics in Understanding Tumor Microenvironment to Drive Segment Growth
Table 86 Spatial Genomics & Transcriptomics Market for Translational Research, by Region, 2020-2027 (USD Million)
Table 87 North America: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
Table 88 Europe: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
Table 89 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
Table 90 Latin America: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
Table 91 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
8.3 Drug Discovery & Development
8.3.1 Rising Use of Rna-Seq in Drug Discovery to Drive Market
Table 92 Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Region, 2020-2027 (USD Million)
Table 93 North America: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 94 Europe: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 95 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 96 Latin America: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
Table 97 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Drug Discovery & Development, by Country, 2020-2027 (USD Million)
9 Spatial Genomics & Transcriptomics Market, by End-user
9.1 Introduction
Table 98 Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
9.2 Academic & Research Institutes
9.2.1 Increased Demand for Spatial Genomics & Transcriptomics in Translational Research to Drive Growth
Table 99 Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Region, 2020-2027 (USD Million)
Table 100 North America: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
Table 101 Europe: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
Table 102 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
Table 103 Latin America: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
Table 104 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
9.3 Contract Research Organizations
9.3.1 Increasing Dependence on Contract Research to Drive Market
Table 105 Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Region, 2020-2027 (USD Million)
Table 106 North America: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 107 Europe: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 108 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 109 Latin America: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 110 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Growing Importance of Biomarkers to Drive Demand for Spatial Genomics & Transcriptomics Systems
Table 111 Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Region, 2020-2027 (USD Million)
Table 112 North America: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 113 Europe: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 114 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 115 Latin America: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 116 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 98 Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
9.2 Academic & Research Institutes
9.2.1 Increased Demand for Spatial Genomics & Transcriptomics in Translational Research to Drive Growth
Table 99 Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Region, 2020-2027 (USD Million)
Table 100 North America: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
Table 101 Europe: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
Table 102 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
Table 103 Latin America: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
Table 104 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Academic & Research Institutes, by Country, 2020-2027 (USD Million)
9.3 Contract Research Organizations
9.3.1 Increasing Dependence on Contract Research to Drive Market
Table 105 Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Region, 2020-2027 (USD Million)
Table 106 North America: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 107 Europe: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 108 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 109 Latin America: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 110 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Growing Importance of Biomarkers to Drive Demand for Spatial Genomics & Transcriptomics Systems
Table 111 Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Region, 2020-2027 (USD Million)
Table 112 North America: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 113 Europe: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 114 Asia-Pacific: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 115 Latin America: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 116 Middle East & Africa: Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2020-2027 (USD Million)
10 Spatial Genomics & Transcriptomics Market, by Region
10.1 Introduction
Figure 23 Spatial Genomics & Transcriptomics Market, by Region, 2022 Vs. 2027 (USD Million)
Table 117 Spatial Genomics & Transcriptomics Market, by Region, 2020-2027 (USD Million)
10.2 North America
Figure 24 North America: Spatial Genomics & Transcriptomics Market Snapshot
Table 118 North America: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 119 North America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 120 North America: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 121 North America: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 122 North America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 123 North America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 124 North America: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.2.1 US
10.2.1.1 Us to Dominate North American Market
Table 125 US: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 126 US: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 127 US: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 128 US: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 129 US: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 130 US: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.2.2 Canada
10.2.2.1 Government Initiatives to Contribute to Market Growth
Table 131 Canada: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 132 Canada: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 133 Canada: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 134 Canada: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 135 Canada: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 136 Canada: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3 Europe
Table 137 Europe: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 138 Europe: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 139 Europe: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 140 Europe: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 141 Europe: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 142 Europe: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 143 Europe: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3.1 Germany
10.3.1.1 Increasing Adoption of Spatial Genomics and Transcriptomics by Biopharma & Biotech Companies to Drive Market Growth
Table 144 Germany: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 145 Germany: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 146 Germany: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 147 Germany: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 148 Germany: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 149 Germany: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3.2 UK
10.3.2.1 Rising Government Support for Biotech Companies to Propel Demand for Advanced Technologies
Table 150 UK: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 151 UK: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 152 UK: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 153 UK: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 154 UK: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 155 UK: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3.3 France
10.3.3.1 Increasing Investments in Life Sciences R&D Infrastructure Development to Support Market Growth
Table 156 France: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 157 France: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 158 France: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 159 France: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 160 France: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 161 France: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3.4 Rest of Europe
Table 162 Roe: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 163 Roe: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 164 Roe: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 165 Roe: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 166 Roe: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 167 Roe: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4 Asia-Pacific
Figure 25 Asia-Pacific: Spatial Genomics & Transcriptomics Market Snapshot
Table 168 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 169 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 170 Asia-Pacific: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 171 Asia-Pacific: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 172 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 173 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 174 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4.1 China
10.4.1.1 Increasing R&D Spending by Government and Biopharma Companies to Support Market Growth
Table 175 China: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 176 China: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 177 China: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 178 China: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 179 China: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 180 China: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4.2 Japan
10.4.2.1 Rising Funding in Japan to Boost Research Applications
Table 181 Japan: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 182 Japan: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 183 Japan: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 184 Japan: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 185 Japan: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 186 Japan: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4.3 India
10.4.3.1 Collaborations Between Hospitals and Diagnostics Centers for Laboratory Services to Boost Growth
Table 187 India: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 188 India: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 189 India: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 190 India: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 191 India: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 192 India: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4.4 Rest of Asia-Pacific
Table 193 Roapac: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 194 Roapac: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 195 Roapac: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 196 Roapac: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 197 Roapac: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 198 Roapac: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.5 Latin America
Table 199 Latin America: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 200 Latin America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 201 Latin America: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 202 Latin America: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 203 Latin America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 204 Latin America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 205 Latin America: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.5.1 Brazil
10.5.1.1 Increased Adoption of Spatial Analysis for Translational Research in Brazil Likely to Propel Market
Table 206 Brazil: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 207 Brazil: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 208 Brazil: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 209 Brazil: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 210 Brazil: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 211 Brazil: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.5.2 Mexico
10.5.2.1 Growing Attention of Investors on Opportunities in Mexico to Support Growth
Table 212 Mexico: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 213 Mexico: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 214 Mexico: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 215 Mexico: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 216 Mexico: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 217 Mexico: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.5.3 Rest of Latin America
Table 218 Rolatam: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 219 Rolatam: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 220 Rolatam: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 221 Rolatam: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 222 Rolatam: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 223 Rolatam: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.6 Middle East & Africa
Table 224 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 225 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 226 Middle East & Africa: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 227 Middle East & Africa: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 228 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 229 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 230 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.6.1 South Africa
10.6.1.1 Growing Investments in R&D to Support Market Development
Table 231 South Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 232 South Africa: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 233 South Africa: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 234 South Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 235 South Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 236 South Africa: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.6.2 Rest of Middle East & Africa
Table 237 Romea: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 238 Romea: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 239 Romea: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 240 Romea: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 241 Romea: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 242 Romea: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
Figure 23 Spatial Genomics & Transcriptomics Market, by Region, 2022 Vs. 2027 (USD Million)
Table 117 Spatial Genomics & Transcriptomics Market, by Region, 2020-2027 (USD Million)
10.2 North America
Figure 24 North America: Spatial Genomics & Transcriptomics Market Snapshot
Table 118 North America: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 119 North America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 120 North America: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 121 North America: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 122 North America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 123 North America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 124 North America: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.2.1 US
10.2.1.1 Us to Dominate North American Market
Table 125 US: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 126 US: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 127 US: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 128 US: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 129 US: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 130 US: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.2.2 Canada
10.2.2.1 Government Initiatives to Contribute to Market Growth
Table 131 Canada: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 132 Canada: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 133 Canada: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 134 Canada: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 135 Canada: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 136 Canada: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3 Europe
Table 137 Europe: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 138 Europe: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 139 Europe: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 140 Europe: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 141 Europe: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 142 Europe: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 143 Europe: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3.1 Germany
10.3.1.1 Increasing Adoption of Spatial Genomics and Transcriptomics by Biopharma & Biotech Companies to Drive Market Growth
Table 144 Germany: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 145 Germany: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 146 Germany: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 147 Germany: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 148 Germany: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 149 Germany: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3.2 UK
10.3.2.1 Rising Government Support for Biotech Companies to Propel Demand for Advanced Technologies
Table 150 UK: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 151 UK: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 152 UK: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 153 UK: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 154 UK: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 155 UK: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3.3 France
10.3.3.1 Increasing Investments in Life Sciences R&D Infrastructure Development to Support Market Growth
Table 156 France: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 157 France: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 158 France: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 159 France: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 160 France: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 161 France: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.3.4 Rest of Europe
Table 162 Roe: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 163 Roe: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 164 Roe: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 165 Roe: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 166 Roe: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 167 Roe: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4 Asia-Pacific
Figure 25 Asia-Pacific: Spatial Genomics & Transcriptomics Market Snapshot
Table 168 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 169 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 170 Asia-Pacific: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 171 Asia-Pacific: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 172 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 173 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 174 Asia-Pacific: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4.1 China
10.4.1.1 Increasing R&D Spending by Government and Biopharma Companies to Support Market Growth
Table 175 China: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 176 China: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 177 China: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 178 China: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 179 China: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 180 China: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4.2 Japan
10.4.2.1 Rising Funding in Japan to Boost Research Applications
Table 181 Japan: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 182 Japan: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 183 Japan: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 184 Japan: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 185 Japan: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 186 Japan: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4.3 India
10.4.3.1 Collaborations Between Hospitals and Diagnostics Centers for Laboratory Services to Boost Growth
Table 187 India: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 188 India: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 189 India: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 190 India: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 191 India: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 192 India: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.4.4 Rest of Asia-Pacific
Table 193 Roapac: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 194 Roapac: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 195 Roapac: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 196 Roapac: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 197 Roapac: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 198 Roapac: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.5 Latin America
Table 199 Latin America: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 200 Latin America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 201 Latin America: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 202 Latin America: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 203 Latin America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 204 Latin America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 205 Latin America: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.5.1 Brazil
10.5.1.1 Increased Adoption of Spatial Analysis for Translational Research in Brazil Likely to Propel Market
Table 206 Brazil: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 207 Brazil: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 208 Brazil: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 209 Brazil: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 210 Brazil: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 211 Brazil: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.5.2 Mexico
10.5.2.1 Growing Attention of Investors on Opportunities in Mexico to Support Growth
Table 212 Mexico: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 213 Mexico: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 214 Mexico: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 215 Mexico: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 216 Mexico: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 217 Mexico: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.5.3 Rest of Latin America
Table 218 Rolatam: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 219 Rolatam: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 220 Rolatam: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 221 Rolatam: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 222 Rolatam: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 223 Rolatam: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.6 Middle East & Africa
Table 224 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Country, 2020-2027 (USD Million)
Table 225 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 226 Middle East & Africa: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 227 Middle East & Africa: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 228 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 229 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 230 Middle East & Africa: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.6.1 South Africa
10.6.1.1 Growing Investments in R&D to Support Market Development
Table 231 South Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 232 South Africa: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 233 South Africa: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 234 South Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 235 South Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 236 South Africa: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
10.6.2 Rest of Middle East & Africa
Table 237 Romea: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 238 Romea: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 239 Romea: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 240 Romea: Spatial Genomics & Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 241 Romea: Spatial Genomics & Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 242 Romea: Spatial Genomics & Transcriptomics Market, by End-user, 2020-2027 (USD Million)
11 Competitive Landscape
11.1 Introduction
11.2 Right-To-Win Strategies Adopted by Key Players
Figure 26 Spatial Genomics & Transcriptomics Market: Strategies Adopted by Key Players
11.3 Revenue Share Analysis (Top Six Players)
Figure 27 Revenue Analysis for Top Six Companies, 2018-2021
11.4 Market Share Analysis (2021)
Figure 28 Spatial Genomics & Transcriptomics Market: Market Share Analysis of Top Six Players (2021)
11.5 Company Evaluation Quadrant
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
Figure 29 Spatial Genomics & Transcriptomics Market: Company Evaluation Quadrant (2021)
11.6 Company Evaluation Quadrant: Start-Ups/Smes
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
Figure 30 Spatial Genomics & Transcriptomics Market: Company Evaluation Quadrant for Start-Ups/Smes (2021)
11.7 Competitive Benchmarking
11.7.1 Spatial Genomics & Transcriptomics Market: Detailed List of Start-Ups/Smes
Table 243 Spatial Genomics & Transcriptomics Market: Detailed List of Start-Ups/Smes
11.7.1.1 Spatial Genomics & Transcriptomics Market: Competitive Benchmarking of Key Players (Start-Ups/Smes)
Table 244 Spatial Genomics & Transcriptomics Market: Competitive Benchmarking of Key Players (Start-Ups/Smes)
11.8 Competitive Scenario and Trends
11.8.1 Deals
Table 245 Spatial Genomics & Transcriptomics Market: Deals
11.8.2 Product Launches
Table 246 Spatial Genomics & Transcriptomics Market: Product Launches
11.8.3 Other Developments
Table 247 Spatial Genomics & Transcriptomics Market: Other Developments
11.2 Right-To-Win Strategies Adopted by Key Players
Figure 26 Spatial Genomics & Transcriptomics Market: Strategies Adopted by Key Players
11.3 Revenue Share Analysis (Top Six Players)
Figure 27 Revenue Analysis for Top Six Companies, 2018-2021
11.4 Market Share Analysis (2021)
Figure 28 Spatial Genomics & Transcriptomics Market: Market Share Analysis of Top Six Players (2021)
11.5 Company Evaluation Quadrant
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
Figure 29 Spatial Genomics & Transcriptomics Market: Company Evaluation Quadrant (2021)
11.6 Company Evaluation Quadrant: Start-Ups/Smes
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
Figure 30 Spatial Genomics & Transcriptomics Market: Company Evaluation Quadrant for Start-Ups/Smes (2021)
11.7 Competitive Benchmarking
11.7.1 Spatial Genomics & Transcriptomics Market: Detailed List of Start-Ups/Smes
Table 243 Spatial Genomics & Transcriptomics Market: Detailed List of Start-Ups/Smes
11.7.1.1 Spatial Genomics & Transcriptomics Market: Competitive Benchmarking of Key Players (Start-Ups/Smes)
Table 244 Spatial Genomics & Transcriptomics Market: Competitive Benchmarking of Key Players (Start-Ups/Smes)
11.8 Competitive Scenario and Trends
11.8.1 Deals
Table 245 Spatial Genomics & Transcriptomics Market: Deals
11.8.2 Product Launches
Table 246 Spatial Genomics & Transcriptomics Market: Product Launches
11.8.3 Other Developments
Table 247 Spatial Genomics & Transcriptomics Market: Other Developments
12 Company Profiles
12.1 Major Players
(Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 Nanostring Technologies
Table 248 Nanostring Technologies: Business Overview
Figure 31 Nanostring Technologies: Company Snapshot (2021)
12.1.2 10X Genomics
Table 249 10X Genomics: Business Overview
Figure 32 10X Genomics: Company Snapshot (2021)
12.1.3 Illumina
Table 250 Illumina: Business Overview
Figure 33 Illumina: Company Snapshot (2021)
12.1.4 Bio-Rad Laboratories
Table 251 Bio-Rad: Business Overview
Figure 34 Bio-Rad: Company Snapshot (2021)
12.1.5 Bio-Techne
Table 252 Bio-Techne: Business Overview
Figure 35 Bio-Techne: Company Snapshot (2021)
12.1.6 Standard Biotools
Table 253 Standard Biotools: Business Overview
Figure 36 Standard Biotools: Company Snapshot (2021)
12.1.7 Genomic Vision Sa
Table 254 Genomic Vision: Business Overview
Figure 37 Genomic Vision: Company Snapshot (2021)
12.1.8 Akoya Biosciences
Table 255 Akoya Biosciences: Business Overview
Figure 38 Akoya Biosciences: Company Snapshot (2021)
12.1.9 Danaher Corporation
Table 256 Danaher Corporation: Business Overview
Figure 39 Danaher Corporation: Company Snapshot (2021)
12.1.10 Natera
Table 257 Natera: Business Overview
Figure 40 Natera: Company Snapshot (2021)
12.1.11 Perkinelmer
Table 258 Perkinelmer: Business Overview
Figure 41 Perkinelmer: Company Snapshot (2021)
12.1.12 Seven Bridges Genomics
Table 259 Seven Bridges Genomics: Business Overview
12.1.13 S2 Genomics
Table 260 S2 Genomics: Business Overview
12.1.14 Cantata Bio
Table 261 Cantata Bio: Business Overview
12.1.15 Vizgen Corp
Table 262 Vizgen: Business Overview
12.2 Other Players
12.2.1 Biospyder Technologies
12.2.2 Optical Biosystems
12.2.3 Miltenyl Biotec
12.2.4 Rarecyte
12.2.5 Ultivue
12.2.6 Lunaphore Technologies
12.2.7 Rebus Biosystems
12.2.8 Resolve Biosciences
12.2.9 Singular Genomics
12.2.10 Veracyte
*Details on Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) Might Not be Captured in Case of Unlisted Companies.
(Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 Nanostring Technologies
Table 248 Nanostring Technologies: Business Overview
Figure 31 Nanostring Technologies: Company Snapshot (2021)
12.1.2 10X Genomics
Table 249 10X Genomics: Business Overview
Figure 32 10X Genomics: Company Snapshot (2021)
12.1.3 Illumina
Table 250 Illumina: Business Overview
Figure 33 Illumina: Company Snapshot (2021)
12.1.4 Bio-Rad Laboratories
Table 251 Bio-Rad: Business Overview
Figure 34 Bio-Rad: Company Snapshot (2021)
12.1.5 Bio-Techne
Table 252 Bio-Techne: Business Overview
Figure 35 Bio-Techne: Company Snapshot (2021)
12.1.6 Standard Biotools
Table 253 Standard Biotools: Business Overview
Figure 36 Standard Biotools: Company Snapshot (2021)
12.1.7 Genomic Vision Sa
Table 254 Genomic Vision: Business Overview
Figure 37 Genomic Vision: Company Snapshot (2021)
12.1.8 Akoya Biosciences
Table 255 Akoya Biosciences: Business Overview
Figure 38 Akoya Biosciences: Company Snapshot (2021)
12.1.9 Danaher Corporation
Table 256 Danaher Corporation: Business Overview
Figure 39 Danaher Corporation: Company Snapshot (2021)
12.1.10 Natera
Table 257 Natera: Business Overview
Figure 40 Natera: Company Snapshot (2021)
12.1.11 Perkinelmer
Table 258 Perkinelmer: Business Overview
Figure 41 Perkinelmer: Company Snapshot (2021)
12.1.12 Seven Bridges Genomics
Table 259 Seven Bridges Genomics: Business Overview
12.1.13 S2 Genomics
Table 260 S2 Genomics: Business Overview
12.1.14 Cantata Bio
Table 261 Cantata Bio: Business Overview
12.1.15 Vizgen Corp
Table 262 Vizgen: Business Overview
12.2 Other Players
12.2.1 Biospyder Technologies
12.2.2 Optical Biosystems
12.2.3 Miltenyl Biotec
12.2.4 Rarecyte
12.2.5 Ultivue
12.2.6 Lunaphore Technologies
12.2.7 Rebus Biosystems
12.2.8 Resolve Biosciences
12.2.9 Singular Genomics
12.2.10 Veracyte
*Details on Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) Might Not be Captured in Case of Unlisted Companies.
13 Appendix
13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options
Companies Mentioned
- 10X Genomics
- Akoya Biosciences
- Bio-Rad Laboratories
- Biospyder Technologies
- Bio-Techne
- Cantata Bio
- Danaher Corporation
- Genomic Vision Sa
- Illumina
- Lunaphore Technologies
- Miltenyl Biotec
- Nanostring Technologies
- Natera
- Optical Biosystems
- Perkinelmer
- Rarecyte
- Rebus Biosystems
- Resolve Biosciences
- S2 Genomics
- Seven Bridges Genomics
- Singular Genomics
- Standard Biotools
- Ultivue
- Veracyte
- Vizgen Corp
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 232 |
| Published | December 2022 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 355 Million |
| Forecasted Market Value ( USD | $ 800 Million |
| Compound Annual Growth Rate | 17.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
